Clinical evidence & real-world use
Evidence to support informed wound-care decisions
Explore published literature, real-world case experiences, and practical resources for PalinGen® Membrane (chorion-free amniotic membrane allograft) in the management of chronic, non-healing wounds.
How to use this page
A clinician- and payor-focused evidence hub
This page summarizes the types of clinical evidence commonly used to evaluate advanced wound care products. For product-specific documents and citations, please use the Resources section or contact LN ALLOG Inc.
Published literature
Peer-reviewed articles and clinical reports that describe outcomes, patient populations, and treatment protocols.
Case spotlight
Real-world examples that illustrate wound characteristics, application approach, and progression over time.
Coding & coverage context
High-level reimbursement considerations, including HCPCS information (e.g., Q4173) and documentation expectations—coverage varies by payer.
Resources for teams
Downloadable materials to support clinical workflows, education, and payer conversations.
Evidence framework
What clinicians and payors typically look for
When evaluating a skin substitute or wound covering, stakeholders often assess both clinical outcomes and the quality of supporting evidence. The sections below outline common endpoints and documentation elements.
✔
Clinical outcomes
Time to closure, percent area reduction, recurrence, infection-related events, and need for additional interventions.
✔
Study quality & applicability
Patient selection, wound type (DFU/VLU/pressure), comparators, follow-up duration, and alignment with real-world practice.
Explore evidence types
From case experience to supporting documentation
Use these pathways to find the information your team needs—whether you’re reviewing a case, preparing a payer packet, or educating staff.
